LeMaitre Vascular (LMAT) Analyst & Key Data

Analyst Consensus

Buy5 analysts

Buy

Updated Sep 12, 2026

Total Analysts5

Buy

14

Hold

6

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score4.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$80.59

Median Target+37.24%

$110.60

Potential upside vs current price

DCF Value+12.18%

$90.40

Potential upside vs current price

Current Stock Price

$80.59

Median Target+37.24%

$110.60

Potential upside vs current price

DCF Value+12.18%

$90.40

Potential upside vs current price

Analyst Consensus

Buy5 analysts

Buy

Updated Sep 12, 2026

Total Analysts5

Buy

14

Hold

6

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score4.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$80.59

Median Target+37.24%

$110.60

Potential upside vs current price

DCF Value+12.18%

$90.40

Potential upside vs current price

Current Stock Price

$80.59

Median Target+37.24%

$110.60

Potential upside vs current price

DCF Value+12.18%

$90.40

Potential upside vs current price

LeMaitre Vascular, Inc.